EFDID: 532939EFD: View Filing

Issuer: Mission BioCapital VI LP (0002039280) - D/A

Accession: 0002039280-25-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002039280
  • Entity Name:
    Mission BioCapital VI LP
  • Entity Type:
    Limited Partnership
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2023)
  • Address:
    139 MAIN STREET, SUITE 401
    CAMBRIDGE, MA 02142
  • Persons:
    Related Persons 2
    General Partner Mission BioCapital VI GP LLC
    Promoter 
    General Partner of the Issuer
    Peter D. Parker
    Executive Officer 
    Manager of the General Partner of the Issuer
EDGAR: Offering Information
  • Accession Date:
    09/26/2025
  • First Sale Date:
    09/30/2024
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $133,750,000
  • Exemptions:
    Section 3(c)(1) , Section 3(c)(7), Investment Company Act Section 3(c) , Rule 506
  • Security Type(s):
    Pooled Investment Fund
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, MN, NY, PA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
BHA Select Network, LLC 168883 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Mission BioCapital VI LP/s/ Peter D. ParkerPeter D. ParkerManager of the General Partner of the Issuer2025-09-26
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Nov. 14, 2025 532939: 0002039280-25-000007 Mission BioCapital VI LP
Amount Sold: $143,750,000
D/A Sep. 26, 2025 532939: 0002039280-25-000003 Mission BioCapital VI LP
Amount Sold: $133,750,000
D Sep. 27, 2024 532939: 0002039280-24-000001 Mission BioCapital VI LP